导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 35.14% | 100/1050 |
| 近一周 | -3.00% | 794/1104 |
| 近一月 | -5.98% | 744/1102 |
| 近一季 | -5.35% | 606/1092 |
| 近半年 | 25.75% | 99/1070 |
| 近一年 | 35.70% | 126/1018 |
| 近两年 | 117.38% | 148/926 |
| 近三年 | 60.31% | 199/833 |
| 成立以来 | 105.15% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.62% 534/1070 |
90.61% 71/1101 |
- - |
- - |
| 2025 | 17.59% 710/1065 |
2.67% 584/1014 |
-3.92% 929/1038 |
32.75% 326/1050 |
-10.21% 887/1065 |
| 2024 | 0.55% 566/1011 |
-12.38% 832/960 |
-4.31% 591/983 |
10.08% 614/991 |
8.95% 71/1011 |
| 2023 | 2.81% 63/952 |
32.83% 7/880 |
-5.31% 546/895 |
-17.88% 831/915 |
-0.47% 142/952 |
| 2022 | -26.17% 534/867 |
-26.62% 728/773 |
4.68% 537/806 |
-8.13% 150/845 |
4.63% 225/867 |
| 2021 | 13.33% 201/740 |
-5.78% 375/580 |
18.46% 180/659 |
-7.53% 439/704 |
9.80% 89/740 |
| 2020 | 43.89% 274/554 |
6.42% 61/419 |
20.10% 284/466 |
0.42% 414/517 |
12.11% 290/554 |
| 2019 | 78.27% 13/410 |
30.16% 369/1146 |
-7.07% 859/1228 |
23.21% 11/390 |
19.61% 16/410 |
| 2018 | -26.86% 174/349 |
- - |
-12.59% 623/990 |
-7.53% 625/1000 |
-13.14% 747/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 创金合信科技成长股票C VS. 东吴新产业精选股票A(580008) |